Federal Reserve Monetary Policy Stance Under Scrutiny Amid Inflation and Growth Concerns Sun Pharma Reports 26 Profit Surge in Q4 FY2026 Proposes 5 Final Dividend Accountants Emerging as Key Drivers of Corporate Sustainability ACCA Survey Indicates Ofcom Raises Concerns TikTok and YouTube May Not Be Adequately Safe for Children Trump Trade Czar Signals Tariffs on Canada Mexico Will Stay Despite USMCA Taiwan Emerges as Pivotal Flashpoint in TrumpXi Summit Discussions GTIM Q1 2026 Earnings Modest Profitability Amid Operational Challenges MCO Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline uniQure Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips ERO Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Higher Copper Prices QUAD Q1 2026 Earnings EPS Beats Estimates by 14 Stock Climbs Marginally GOOGL Q1 2026 Earnings EPS Misses Estimates as Revenue Uncertainty Weighs on Sentiment BlackRock Science and Technology Trust BST Advances 155 as Growth Stocks Find Favor Bridger Aerospace Group Holdings Warrants BAERW Hover Near Support Amid Modest Decline Idea Acquisition Corp Units IACOU Holds Steady Near 10 Amid Low Volatility EPower Inc EPOW Slides 28 as Shares Test Key Support at 066 LivaNova LIVN Retreats 183 as Stock Faces Resistance Near 78 Zone Micron Stock Surges Toward Best Month Since 1987 as Analysts See Further Value Century Communities Q1 2026 Earnings Strong EPS Beat Amid Housing Market Headwinds Prothena PRTA Edges Lower Near Support as Biotech Sector Faces Headwinds XOMAO Q1 2026 Earnings EPS Misses Estimates by Wide Margin CDP Q1 2026 Earnings EPS Surpasses Estimates with 2 Beat Dana Incorporated DAN Q1 2026 Earnings EPS Misses Consensus Amid Mixed Operating Environment Tetra Technologies TTI Q1 2026 Earnings EPS Beat Drives 81 Surprise Amid Revenue Disclosures Lacking SNCY Q1 2026 Earnings EPS Misses Estimates Amid Operational Pressures TSM Q1 2026 Earnings Strong EPS Beat Signals Robust Demand Amid Cautious Market Response NGNE Q1 2026 Earnings EPS Misses Estimates as Biotech Continues RD Focus